Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical events

This publication has 26 references indexed in Scilit:

• Angiographic progression of coronary artery disease and the development of myocardial infarction
  Published by Elsevier ,2004
• Pravastatin, lipids, and major coronary events
  The American Journal of Cardiology, 1994
• Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease
  The Lancet, 1994
• Platelet aggregation, coronary artery disease progression and future coronary events
  The American Journal of Cardiology, 1994
• Long-term prognosis of medically treated patients with acute myocardial infarction and one-vessel coronary artery disease
  The American Journal of Cardiology, 1994
• Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors
  The American Journal of Cardiology, 1993
• Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I)
  The American Journal of Cardiology, 1993
• Progression of coronary atherosclerosis: Is coronary spasm related to progression?
  Journal of the American College of Cardiology, 1991
• Can lifestyle changes reverse coronary heart disease?: The Lifestyle Heart Trial
  Published by Elsevier ,1990
• Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
  New England Journal of Medicine, 1986